A carregar...

Effects of lapatinib or trastuzumab, alone and in combination, in human epidermal growth factor receptor 2‐positive breast cancer: a meta‐analysis of randomized controlled trials

This meta‐analysis compared the efficiency and safety of lapatinib and trastuzumab, alone or in combination, administered with neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer. For dichotomous variables, the relative risk ratio (RR) and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Xin, Yong, Guo, Wen Wen, Huang, Qian, Zhang, Pei, Zhang, Long‐Zhen, Jiang, Guan, Tian, Ye
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5224855/
https://ncbi.nlm.nih.gov/pubmed/27882700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.963
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!